IBRN ETF
iShares Neuroscience and Healthcare ETF
IBRN ETF Overview
IBRN ETF (iShares Neuroscience and Healthcare ETF) is managed by iShares by BlackRock (US) with $6.1M in net assets. IBRN expense ratio is 0.47%, holding 80 positions across sectors including Health Care, Financials. Inception date: 2022-08-24.
IBRN performance shows a YTD return of 4.50%. The 1-year return is 23.94%. IBRN dividend yield stands at 0.96%, paid annually.
IBRN top holdings include Biogen Inc. Com (4.7%), Edgewise Therapeutics Inc. (4.4%), Ptc Therapeutics Inc (4.3%), Argenx Se Sponsored Adr (1 Ads : 1 Ordinary) (4.3%), Neurocrine Biosciences Inc (4.3%). Go to all IBRN holdings, IBRN sectors, or IBRN dividends.
IBRN can be compared against other funds. Use IBRN overlap to find shared positions, or IBRN vs another fund for a side-by-side view. IBRN alternatives are available via the screener, along with tax-loss harvesting opportunities.